Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.37
Delayed Data
As of 4:02pm ET
 +0.02 / +0.37%
Today’s Change
3.50
Today|||52-Week Range
8.30
-6.93%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.35
Today’s open5.38
Day’s range5.34 - 5.54
Volume2,030,134
Average volume (3 months)3,237,154
Market cap$1.1B
Dividend yield--
Data as of 4:02pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book8.25

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.09+0.42%
XNCRXencor Inc-0.62-2.62%
EGRXEagle Pharmaceutical...+0.04+0.05%
ESPREsperion Therapeutic...+2.60+5.63%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts